C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12N 15/11 (2006.01) C12N 15/63 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2255143
The present application relates to a protein which inhibits the cellular protein p27 and thereby relieves the inhibition of the proliferation of the cell which is brought about by p27, mutants thereof, some of which possess a dominant interfering character, the corresponding nucleic acids which encode the protein and the use of proteins and nucleic acids for the prophylaxis and therapy of diseases. The application furthermore discloses nucleic acid constructs for the gene therapy of diseases, which constructs comprise the abovementioned nucleic acids.
Buergin Andrea
Eilers Martin
Sedlacek Hans-Harald
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Marion Roussel Deutschland Gmbh
LandOfFree
Binding partners for inhibitors of cyclin-dependent kinases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding partners for inhibitors of cyclin-dependent kinases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding partners for inhibitors of cyclin-dependent kinases... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1908841